NCT05042453View on ClinicalTrials.gov

Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse

RecruitingOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2030

Conditions
Pelvic Organ Prolapse
Interventions
DEVICE

Splentis® POP Tissue Anchoring System

Anterior cervicopexy with bilateral sacrospinous ligament fixation using Splentis

Trial Locations (7)

Unknown

RECRUITING

DRK Hospital Chemnitz-Rabenstein, Chemnitz

RECRUITING

Helios Hospital Erfurt, Department of gynaecology, Erfurt

RECRUITING

University Hospital Freiburg, Freiburg im Breisgau

RECRUITING

Clinic Kassel, Kassel

RECRUITING

St. Elisabeth Hospital, Leipzig

NOT_YET_RECRUITING

University Hospital, Mannheim

RECRUITING

Hospital Tettnang, Tettnang

All Listed Sponsors
lead

Promedon

INDUSTRY